“In the Know” features conversations with the people and personalities in biopharma.

Camille Samuels is one of just a smattering of female biopharma venture capitalists. But she doesn’t get too hung up on that fact: As a partner at Palo Alto’s Venrock and self-professed “math and science geek,” she prefers to focus solely on forging companies and making deals.

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of news in health and medicine